| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267666.1 |
Vorinostat |
Esophageal cancer |
0.013045328 |
Resistant |
| ENSG00000267666.1 |
Vorinostat |
Sarcoma |
0.016541966 |
Resistant |
| ENSG00000267666.1 |
Vorinostat |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02948768 |
Sensitive |
| ENSG00000267666.1 |
Vorinostat |
Lung squamous cell carcinoma |
0.020027138 |
Sensitive |
